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INTRODUCTION 
 
Organophosphorous compound poisoning is an important public health problem 
in developing countries. Deliberate self harm is responsible for about 500,000 
deaths in South East Asian countries per year and about 60% of these are due to 
insecticide poisoning, of which 66% are constituted by organophosphorous 
compound poisoning.1  
 Insecticide poisoning is very common in South Indian states mainly because of 
their florid agricultural activities and accounts for a significant proportion of 
admissions to ICU in this region. Easy accessibility and lenient rules and 
regulations regarding sales makes organophosphorous compounds one of the 
most commonly used means for deliberate self-harm. Accidental exposure is also 
common in factory workers and agricultural labourers. 
Various hospital statistics have reported mortality rate of OP poisoning varying 
from 20% to 40%.2 Early identification and aggressive management is often 
lifesaving in this condition. As Indian ICUs are often overcrowded and resource 
poor, it may not be fully possible to identify and properly manage patients who 
develop complications of OP poisoning. This scenario highlights the need for 
predictive prognostic markers. If a clinical sign or a symptom or a lab value is 
useful in predicting deterioration in OP poisoning, it will be easy for the clinicians 
to stratify the patients according to risk of developing respiratory failure and 
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arrange ventilator support for them. Many clinical and lab parameters have been 
proposed to assess the severity of poisoning and to predict the need for ventilator 
support in patients admitted with OP poisoning. This study is undertaken to 
analyse the role of some clinical and biochemical parameters in predicting the 
severity of OP poisoning and its clinical outcome. 
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AIMS AND OBJECTIVES 
 
 
1. To study the prognostic value of clinical parameters as assessed by 
Peradeniya OP poisoning scale in predicting the severity of 
organophosphorous compound poisoning. 
 
2. To study the prognostic value of biochemical parameters such as serum 
Pseudocholinesterase and serum Potassium in predicting the severity of 
organophosphorous compound poisoning. 
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REVIEW OF LITERATURE 
                                    “Anything in excess is a poison” 
Once the demand increases, the technology improves and hence the supply. The 
demand for insecticides in an agricultural country like India is very high and the 
market is often conquered by organophosphorous compounds. Suicidal or 
accidental, the exposure of these pesticides and insecticides, because of their high 
toxicity is often life threatening to human beings. 
OP compounds are widely used in agriculture, home and garden. It can reach 
human body through dermal absorption, ingestion or inhalation. It can cause 
acetylcholinesterase phosphorylation at nerve terminals. This finally ends in 
excessive collection of Ach in the nerve endings and results in clinical 
manifestations such as muscarinic, nicotinic as well as central effects. 
The common use of these compounds in the various sectors of our life has led to 
environmental pollution as well as severe health hazards such as poisoning. As 
acetylcholine and inhibition of acetylcholinesterase plays an important role in the 
pathophysiology of OP poisoning it is important to review the physiology of 
cholinergic transmission in our body. 
                                       ACETYLCHOLINE 
Acetylcholine is one of most abundant neurotransmitters in the human body. It is 
an organic chemical, C7NH16O2
+, a derivative of choline and acetic acid. It is often 
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described as vagus stuff as its action mimics vagus nerve stimulation. It was the 
first neurotransmitter discovered by Otto Loewi. In the peripheral nervous 
system, it is mainly found at the neuromuscular junction while in the central 
nervous system it is predominantly seen in the interneurons. It is a 
neurotransmitter in the preganglionic parasympathetic and sympathetic neurons 
in the autonomic nervous system. It is also present in the adrenal medulla, sweat 
glands and piloerector muscle. In the central nervous system, acetyl choline is 
meant for cognition, locomotion, anti-nociception and overall brain activities. 3 
Some of the important functions of acetyl choline in the central nervous system 
are 
a) Arousal and sleep: 
The basal forebrain complex made up of nicotinic and non-nicotinic 
interconnections is responsible for arousal and sleep. Cholinergic neurons 
through stimulation of nucleus basalis/septal nucleus is responsible for 
behavioural arousal.4 
b)  Cognition: 
Hippocampus and posterior parietal cortex mediates latent inhibition 
through cholinergic stimulus. Cholinergic innervation of frontal cortex, 
rostral from nucleus basalis mediates attentional functions. It is also 
important for divided attention which is mediated by pedunculo pontine 
tegmental nucleus through striatum with dopaminergic system. Muscarinic 
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receptors present in hippocampus, prefrontal cortex and amygdala also 
mediates cognitive process.5 Loss of cholinergic neurons can result in 
Alzheimer’s disease, Parkinsons disease, Lewi body dementia and 
progressive supra nuclear palsy.  
c)  Motivation and reward: 
Mesolimbic tegmental nucleus and ventral tegmental area is meant for 
motivation and reward. Pedunculo pontine tegmental nucleus stimulates 
ventral tegmental area and cause mesostriatal dopaminergic transmission 
which results in motivation.6  
Synthesis of Acetyl Choline: 
Cholinergic cell body produces choline acetyl transferase which is transported to 
the axons. This choline acetyl transferase catalyses single step reaction of choline 
with acetyl CoA. Choline is available in the synaptic cleft from the breaking down 
of phosphatidyl choline and also from recycling of acetyl choline metabolites. 
Calcium plays an important role in regulation and uptake of these metabolites. 
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Figure1: Schematic diagram of cholinergic synapse. 
 
Figure 2: structure of acetylcholine receptor 
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Storage of Acetyl Choline: 
Majority of acetyl choline is stored in the presynaptic vesicles and small amount 
is free in the cytosol. Acetyl choline in the vesicle is not degraded by acetyl 
cholinesterase. Energy dependant pump acidifies the vesicle and causes uptake 
of acetyl choline. Acidified vesicle uses vesicular acetyl transporter to exchange 
protons (H+) for acetyl choline molecules. 
Acetyl choline receptors: 
Acetyl choline receptors are the membrane proteins responsible for binding of 
acetyl choline. There are two types of acetyl choline receptors – Nicotinic and 
Muscarinic. 
A) Nicotinic receptors:  
Nicotinic receptors binds to nicotine and mediates excitation in target cells. They 
are linked to ionic channels and causes brief and fast responses. They are located 
in the neuromuscular junction, autonomic ganglia and rarely in the central 
nervous system.  
Inside the brain nicotinic β2 subunit mediates presynaptic regulation of GABA 
release in most areas and β4 mediates nicotinic acetyl choline release in 
interpeduncular areas while α7 subunit mediates the same function in 
hippocampus.7 
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b) Muscarinic receptors: 
Muscarinic receptors belong to the group of G protein coupled receptors. G 
protein consists of α, β, and γ subunits. It is composed of a single polypeptide. 
Amino acids are arranged in an α helix fashion in seven regions of this 
polypeptide.8 
The α subunit of G protein release GDP and binds to GTP. This activates G 
protein leading to dissociation of α subunit which mediates specific responses. 
GTP is hydrolysed by GTPase to GDP and terminates action of GTP. This 
mechanism is involved in the inhibition of adenylate cyclase, activation of 
potassium channels and stimulation of phospholipase C. Muscarinic receptors are 
present both in the pre and post synaptic regions (table1) 
 
                    Table 1- Muscarinic receptors and distribution 
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Structure Of Ach Receptor: 
Ach receptor is a pentameric complex with four essential proteins- α 2 βγδ 
(figure2).  The cytoplasmic side of membrane is made of intra cellular proteins. 
Some proteins show phosphatase activity and some exhibit actin binding activity. 
This molecule projects into the synapse as a funnel shaped structure. The subunits 
surround the ion channel and extends into the synaptic space. The Ach receptors 
which are present in the neuromuscular junction shows functional and 
morphological similarities with cells called ‘electrocytes’ seen in electric fish and 
torpedo and much of our understanding about these complex structures come 
from those analyses. 
Subunits are arranged in such a way that each subunit is accessible to proteolytic 
cleavage by trypsin on either side of the membrane. The receptor has extra 
cellular, membranous and cytoplasmic domains based on the hydrophobicity of 
amino acid residues. 
The one best characterised ligand binding sites on the receptor are two high 
affinity agonist binding sites-one on each alpha sub unit. Agonist binding to these 
sites lead to conformational changes resulting in channel opening or 
desensitisation. The agonist binding is influenced by glycosylation of α subunit. 
The amino acid residues involved in the ion channel function are mainly localised 
to the membrane domain. It consists of close packed amphipathic helices with 
each subunit contributing to the hydrophilic part. The conductance properties of 
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ion channel varies with the conformational changes in the side chains as the side 
chains do not interact directly with the cations. 
ACETYLCHOLINE NEURO TRANSMISSION 
The presynaptic vesicles contain Ach which is released in a quantum manner. The 
release of Ach is influenced by calcium influx through the voltage gated calcium 
channels. Voltage gated sodium channels in the axon triggers opening of these 
calcium channels. Ach is released by the fusion of cell membrane with nearby 
Ach containing vesicles (figure1). 
  Binding of Ach to the receptor leads to the opening of ion channel and passage 
of sodium ions into the synaptic space by sodium potassium ATPase. Each Ach 
receptor molecule conducts about 104 ions per millie second. At least two Ach 
molecules per Ach receptor are required to open the ion channel.10 Two alpha 
subunits bind with Ach and contain binding sites for activating agonist. Each Ach 
receptor closes within 0.1-10 millie second. 
  Ach is hydrolysed in the synaptic space by the action of acetylcholinesterase and 
action disappears.11 If the agonist is present for a long time, the receptor is 
desensitised. The receptor activity is modulated by calcium, phosphorylation of 
cytoplasmic sites, N and O glycosylation and presence of fatty acids. It is also 
influenced by non- physiological agents like neurotoxins, curare and muscle 
relaxants and local anaesthetics 
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Ach in the synaptic space is hydrolysed by the enzyme acetylcholinesterase into 
choline and acetic acid. This enzyme is present throughout the neurons by 
axoplasmic transport. 
ACETYLCHOLINESTERASE 
Acetylcholinesterase is the enzyme responsible for termination cholinergic 
impulse transmission. It causes hydrolysis of acetylcholine into choline and 
acetate. The efficiency of the enzyme is such that it breaks down about 10000 
Ach molecules per second. 
 Certain compounds like organophosphate chemicals, carbamates and sulfonyl 
halides form covalent bond in the active site of the enzyme and act as inhibitors 
of acetylcholinesterase. 
 This enzyme belongs to the group of hydrolases and is ellipsoidal in shape. It has 
eight β strands connected by α helices. The enzyme has a site called catalytic triad 
which contains three amino acids –glutamate, histidine and serine. The catalytic 
triad is present in the in the active site ‘gorge’ at its bottom and penetrate half 
way into the enzyme .12The active site or ‘gorge’ contains two active sub sites – 
the esteratic and anionic sites. Esteratic site is meant for catalytic activity while 
anionic site is for binding quaternary group of acetylcholine. The enzyme has also 
got additional binding sites for Ach and other quaternary ligands. The gorge site 
is lined by large number of aromatic amino acid residues mainly tryptophan and 
this peripheral anionic sites at gorge entrance causes substrate inhibition 
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         Figure 3: Structure of acetylcholinesterase 
The six conservative aromatic residues lining the gorge sites differentiate 
between acetylcholinesterase from butyl cholinesterase.  
The catalytic triad of three amino acids-glutamate, histidine and serine are 
arranged in such a way that glutamate and histidine donate electrons to serine. 
This active serine residue forms covalent bonds with the acetylcholine. It forms 
a ‘tetrahedral intermediate oxyanion’ which is stabilised by interaction with 
amide group and forms an oxyanion hole.13Now the covalent bond is broken 
releasing acetate and choline. It is a two-step acylation and deacylation process. 
The catalytic reaction is also affected by the nature of the substrate. The binding 
of the substrate into the active site of enzyme determines the efficiency of the 
catalysis. The exact fit of thioesters and carbaric esters make them good substrates 
14 
 
for catalysis while organophosphosphorous compounds by their different 
geometry produces irreversible inhibition of the enzyme. 
                     ORGANOPHOSPHATE COMPOUNDS 
HISTORY: 
The use of chemical substances for the control of pests and insects can be traced 
back to ancient Roman civilization. Arsenic and its derivatives were the first used 
insecticides in the early 19th century. Industrial revolution brought about a wide 
variety of compounds ranging from pyrethroids, organophosphates and 
organochlorines. The first mile stone in this development was synthesis of 
Dichloro Diphenyl Trichloroethane(DDT) by Zeidler. History of 
organophosphorous compounds are closely related to Second World War when a 
German chemist, Gerhard Schrader (figure-4) developed chemicals which 
produced neuroparalysis in humans. These were popularly called as ‘nerve 
gases’.                               Figure 4: Gerhard Schrader 
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CHEMISTRY: 
Organophosphate compounds are organic compounds containing phosphorous. It 
comprises of a wide class of compounds with varying oxidation states and 
phosphorous derivatives. The general chemical structure of OPC consists of a      
phosphorous (V) centre which is tetra substituted, an O or S atom double bonded 
to phosphorous, a leaving group and two substituents which varies with the 
subclass14( figure 5). OP compounds are synthesised by the esterification reaction 
between phosphoric acid and alcohols. They are usually esters, amides or thiol 
derivatives. The three main chemical groups of OP compounds are as follows: 
             1. Pure phosphates - No sulphur atom present 
            2. Phosphorothioates - One sulphur atom present 
            3. Phosphorodithioate - Two sulphur atoms present 
 
                                Figure 5: Structure of OP compound 
The hydrolysis of these compounds depends on the type of compound, medium, 
acidity and catalyst used15. The special highly unstable molecular structure with 
easy hydrolysable nature and short period environmental collection increases its 
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market value as a good pesticide. Chemical structures of some of the commonly 
used OP compounds are depicted below (figure 6). 
 
               Figure 6: Chemical structure of common OP compounds 
 
CLASSIFICATION OF OP COMPOUNDS: 
WHO, in 1992, classified OP compounds based on their chemical formulation 
and toxicity profile.1 (table 2) 
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                          Table 2: WHO classification of OP compounds 
Highly toxic organophosphate have LD50 value less than 50mg/kg. 
E.g.: Gathion, Gusathion ,Chlorthiophos ,Chlormephos ,Parathion, Theophos, 
Famphose  
Moderately toxic compounds have LD50 value more than 50mg/kg and less than 
500mg/kg. 
Eg: Acephate , Bromophos ,Cyanophos , Diazinon , Fenmion , Formohion , 
Crotoxyphos , Leptophos , Malathion , Temephos , Trichlorfon  
Some of these compounds are used as nerve agents. They are classified into two 
main categories 16: 
i. Non persistent G agents( Sarin, Soman, Tabun ) 
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- Effected mainly through inhalation 
ii.  Persistent V agents (VE,VG) 
-Effected mainly through inhalation & dermal absorption 
Parathion group of OP compounds shows excellent insecticidal properties and are 
highly toxic. Their toxicity is reduced by replacing alkyl group by methyl esters. 
Delayed toxicity is expressed by certain compounds such as Diazinon, Fenthion, 
and Methyl parathion due to their lipid solubility allowing for fat storage and late 
release.17 
TOXICOKINETICS: 
These chemicals are absorbed through skin, respiratory as well as gastro intestinal 
mucosa. Presence of local inflammation such as dermatitis enhances cutaneous 
absorption of the compound. Cutaneous absorption is directly proportional to the 
contact time. Absorbed compounds is excreted in exhaled air, faeces and urine. 
The three enzyme pathways that are involved in the biotransformation of OP 
compounds are mixed function oxidases (MFO), hydrolases and transferases. 
MFO system is present in the liver, kidney and intestines. This xenobiotic 
reaction requires NADPH and oxygen for catalysis.18 
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GLOBAL SCENARIO: 
Organophosphate compounds contribute to the majority of insecticide related 
hospitalisation especially in agricultural countries. The easy availability, cheap 
rate of these products and low risk awareness among population are the major 
reasons behind this. 
According to WHO,  there are around 3 million hospital admissions for pesticide 
poisoning each year, which result in 2,20,000 deaths.19 Majority of insecticides 
poisoning are due to Organophosphates, Paraquat and Carbamates. According to 
various studies, 63% of insecticide hospitalisations are due to OP compounds, 
73% are occupational hazards and 36% results in death.20 
The accidental exposure can occur because of lack of adequate labelling, easy 
access for children, during mixing and dispersion. Spray operators are mainly 
affected.  Entire population is equally exposed to these poisons by environmental 
contamination or inappropriate cleaning of these products before consumption. 
Occupational exposure is also very high during each stage of its production. 
EPIDEMIOLOGY: 
The first OP toxicity in India was reported by Patel et al in 1962.21 The three most 
important OP compounds manufactured in India are Malathion, Monocrotophos 
and Parthion. Davies and Freed 22reported 145 cases of Parathion poisoning in 
Florida, USA in early 1960s. Repetto and Baliga23 in 1996, concluded that though 
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the use of OP compound is restricted in developed countries, it is still increasing 
in South East Asian countries and India. About 15,000 patients are admitted with 
OP poisoning in Srilankan hospitals annually and 15% of them die.(Jayaratnam 
et al)24. The first case series about an epidemic of OP intoxication was reported 
by Baker et al25 in 1978 about accidental Malathion poisoning in Pakistani 
malaria control workers. Ganapathi et al26 in Madurai concluded that 45.5% of 
suicides were by consuming OP compounds. 
MECHANISM OF ACTION: 
Organophosphate compounds, because of their molecular mimicry binds to 
cholinesterase enzyme. They form a phosphate covalent bond to serine active 
sites of cholinesterases – acetyl cholinesterase and pseudocholinesterase (serum 
cholinesterase). These cholinesterase are meant to hydrolyse Ach into choline and 
acetic acid. Choline moiety is transported back to presynaptic neuron and 
converted to acetyl choline. The phosphorylation of the enzyme occurs when an 
organophosphate leaving group leaves and the compound forms a covalent bond 
with the enzyme. This phosphorylated enzyme is highly stable . Serine group 
which is now inhibited by phosphoryl group will not be able to take part in 
acetylcholine hydrolysis. According to the aging theory, when the enzyme is 
inhibited by phosphate moiety of the OP compound, a component of OP-serine 
conjugate is dealkylated making the enzyme resistant to nucleophilic attack and 
the enzyme is eventually irreversibly inhibited (Figure 7).27 Aged enzyme cannot 
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be reactivated. Inhibition of cholinesterase results in collection of Ach and 
overstimulation of Ach receptor sites which affects muscarinic neuroeffector 
sites, nicotinic receptors within sympathetic ganglia and skeletal myoneural 
junctions and Ach receptor sites within the central nervous system.28 
 
 
 
          Figure 7: Mechanism of AchE inhibition (X is the leaving group) 
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PATHOPHYSIOLOGY: 
The pathological effects of OP compounds on various systems of our body are: 
1. Respiratory system:  
OP compounds cause respiratory muscle paralysis. The patient may be presenting 
with bradypnoea which can terminate in apnoea, chest tightness, wheezing and 
productive cough. Respiratory failure is the main cause of death and can be due 
to respiratory centre inhibition or bronchoconstriction.29 
 
2. Cardiovascular system:  
Acute OP poisoning can cause myocardial cell death resulting in elevation of 
creatinine kinase and lactate dehydrogenase levels in the blood.30 The classical 
sign is bradycardia .Patient may be presenting with abnormal heart rate, altered 
volume status and arrhythmias. ECG changes can be ST elevation, prolonged QT 
interval and PR interval and low amplitude T waves. 
3. Central nervous system: 
Neuronal damage leading to delay in stimulus classification may continue even 
up to 6 months. It can manifest as cerebellar syndromes, Parkinsonian signs, 
altered memory etc.31 
4. Hepatobiliary System: 
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Since liver is the site for OP biotransformation, sometimes there can be 
congestion, necrosis, and inflammation of hepatocytes and dilatation of 
sinusoidal cells.32 
5. Renal System: 
Organophosphate compounds are risk factors for glycosuria,3renal failure and 
sometimes even for renal cancer.33 
6. Endocrine System: 
OP compounds mainly affects sex hormones resulting in hypogonadism.34 
SYMPTOMATOLOGY: 
The clinical presentation of OP compound toxicity varies with the mode of 
absorption which is fastest for inhalation, followed by oral and then dermal route. 
Early symptoms can be headache, dizziness or vomiting. Gradually the patient 
may develop signs of increased secretions like sweating, salivation, rhinorrhoea 
and lacrimation. Other important signs are miosis and blurring of vision 
.Usually, the order of clinical manifestation is miosis followed by GIT 
symptoms and hyper salivation. Muscarinic signs are the first clinical 
manifestations often noticed. OP compounds can cause seizures, lethargy and 
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flaccid muscle weakness in children .35The symptoms are summarised in table3  
 
                           Table 3: Symptoms of OP poisoning 
Inhalation of OP compounds can cause cough, dyspnoea, pneumonia etc.  If 
exposed to eyes, the patient will develop photophobia, irritation, pain, lacrimation 
or blurring of vision.14 
The presentation can be: 
1. Cholinergic syndrome/ crisis: 
 Accumulation of Ach in the nerve terminal results in hyper stimulation of 
cholinergic receptors – both muscarinic and nicotinic. The patient will have 
hyper secretions, muscle fasciculations, muscle cramps, miosis, diarrhoea, 
increased gastrointestinal motility, etc. 36LMN type of muscle weakness can 
develop which mainly affects respiratory muscles resulting in respiratory 
failure. 
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2. Type II paralysis/Intermediate syndrome: 
 Desensitization of nicotinic receptor due to sustained cholinergic stimulation 
is responsible for intermediate syndrome. It may arise several days after 
exposure or even after cholinergic syndrome and may persist for 4-18 days. 
There will be paralysis of extra-ocular muscles, respiratory muscles, neck and 
limb muscles.37 Neck muscle weakness is the most common manifestation. 
 
 
3. Type III paralysis-Organophosphate induced delayed       
polyneuropathy: 
It develops 2-3 weeks after the exposure of OP compounds as some of these 
compounds can cause phosphorylation of neuronal target esterase, present 
in nerve tissues as well as other tissues.38 Chronic exposure or OP 
compounds in large doses is responsible for OIDP. 
Some of the OP compounds like Methamidophos and Trichlorfon, due to 
their peculiar structure that can cause ageing of  NTE , are responsible for 
OIDP. It can finally end up in neuronal degeneration .Patient will have 
sensory loss, tingling over extremities, progressive muscle weakness and 
flaccidity of distal skeletal muscles. Patient may suffer from this even for 
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one year and methylprednisolone in high doses is suggested to be the 
treatment of choice. 
4. Long term toxicity : 
Certain studies show that acute exposure of OP compounds in large dose can 
sometimes result in long term effects which is mainly manifested as 
neurological abnormalities like cerebral and cerebellar degenerations.35 
CLINICAL SCORES FOR THE ASSESSMENT OF POISONING 
SEVERITY: 
For proper management of OP poisoning, adequate scoring systems based on 
the laboratory investigations and clinical manifestations are needed to assess 
the severity and progress. This is best done using GCS (Glasgow Coma Scale), 
APACHE –II (Acute Physiology and Chronic Health Evaluation II), PSS 
(Poison Severity Score) scoring system and Peradeniya OP poisoning scale 
1. Glasgow Coma Scale (GCS): 
GCS is a neurological scale used to assess the consciousness of the patient. 
The scoring is based on best eye response, best verbal response and best 
motor response. 39It is assigned as severe (GCS< 8) ; moderate (GCS 9-12) 
and minor  (GCS >13).Maximum value is 15 and minimum is 3. Score < 8 
signifies complications and the patient may be in need of intubation. This 
scoring systems is more advantageous than the other scoring systems as it 
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does not require any laboratory investigations and is quick to apply (Table 
4) 
 
 
                            Table 4: Glasgow Coma Scale 
 
2. Acute Physiology And Chronic Health Evaluation-II (APACHE-II): 
APACHE –II scoring system is used to assess the morbidity of the patient 
especially for those above 15 years of age. It is calculated from 12 
parameters which includes temperature, mean arterial pressure, heart rate, 
respiratory rate, partial oxygen pressure, serum sodium, serum potassium, 
serum creatinine, haematocrit, white blood cell count and GCS. 
40.APACHE score is derived by adding Total Acute Physiology Score (A) 
which is the sum of all these 12 values, with age points (B) and chronic 
28 
 
health points like any organ insufficiency. Always APACHE score will be 
inversely related to the prognosis(Table 5). 
 
                                  Table 5:APACHE II score 
3. Poison Severity Score (PSS): 
Severity is assessed using the overall clinical features and outcome is 
predicted using the PSS score. The grading will be 0 for no symptoms or 
signs; grade 1 for mild or transient, spontaneously resolving; grade 2 for 
moderate ,pronounced or prolonged symptoms; grade 3 for severe or life 
threatening symptoms and grade 4 for extremely severe toxicity.41 
4. Peradeniya Organophosphorous poisoning scale (POP): 
POP scale screening should be done as soon as the patient is admitted and 
before starting any treatment .It helps in assessing the cholinergic effects. 
The parameters used are respiratory rate, heart rate, pupil size, 
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fasiculations, seizure and level of consciousness. 42It can be graded as mild 
0-3 ; moderate :4-7 and severe :8-11 
 
                         Table 6: Peradeniya OP poisonng scale 
CONFIRMATION OF OP COMPOUND POISONING: 
OP compound poisoning can be confirmed by analysing the levels of BuChE and 
RBC AchE levels. AchE depression to less than 20% means significant 
poisoning, while 20-40 % means moderate poisoning. But the specificity is less 
as cholinesterase levels can be decreased in hepatitis/ malnutrition / alcoholism / 
dermatomyositis. 
Other method is to identify and quantify the insecticide present even at low levels 
after 48 hours using urinary alkyl phosphate and phenol analysis.43 
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DETECTION OF OP COMPOUNDS: 
OP compound poisoning is in an increasing trend now a days. Certain 
organisations are interested in setting the maximum permissible level of these 
compounds in food and water. FAO, WHO and US environmental protection 
agencies are some of these. 
They mainly use chromatographic methods and spectrometry. Some of the other 
methods used are enzymatic assays, calorimetric methods, interferometry, 
surface acoustic waves, enzyme biosensors and molecular imprinting with 
luminescence. 
1. Biosensors based on enzyme inhibition: 
The biosensors works on the principle that OP Compounds act by inhibiting AchE 
.It can be assessed directly or indirectly. 
 In direct method, thiocholine produced in the hydrolysis of acetyl 
 Choline in the presence of water and acetyl choline esterase is measured.44 
OP compounds causes AChE inhibition decreasing the thiocholine level. 
Another method is two-enzyme approach. Choline produced in the reaction of 
acetyl choline with AchE is acted upon by choline oxidase which finally results 
in Betaine and H2O2  formation. 
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Acetylcholine +H2O                                          Choline + acetic acid 
Choline + 2O2 + H2O                                         Betaine +2H2O 
Oxidation of H2O2 is measured amperometrically. This biosensors work with 
carbon nanotube along with acetylcholine esterase and choline oxidase enzyme 
immobilisation.  
2. Fluorescence based detection: 
This method is more beneficial than other methods due to its high specificity, 
short time results and results even for small amount of sample. For this, a good 
sensor with ability to form a specific binding between receptor molecule and 
target along with the ability to assess the gap between nanopeptide and 
flurophore, based on target molecule concentration is used.45 
Another very sensitive method- even for nanomole concentration is detection 
using pH-sensitive fluorescent dye. For quick result, gold nanoparticle based 
surface enhanced fluorescence spectroscopy is used. Eu3+ ions released from gold 
nanoparticle surface shows fluorescent signal in the organophosphate 
compounds. 
3. Immunological determination: 
Immunological determination is highly reliable, selective, specific and sensitive 
method. ELISA method is used for diazinon, fenthion, malathion, and 
      AchE 
Choline oxidase 
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chlorpyrifos. Phosphorylated AchE is used as a potential biomarker of OP 
agents.46 
4. Microfluidics based detection: 
The advantages of microfluidic based detection is that detection can be done for 
minute samples and even for the total sample on the same platform.47 This 
technique involves continuous flow of blood and sequential analysis of whole 
blood and breaking down of the complex of organophosphate compounds from 
cholinesterase and its detection. 
MANAGEMENT 
A patient brought to the hospital with exposure to organophosphorous 
compounds should be approached in such a way that further exposure to the 
substance is prevented, product is removed from the body and the toxins inside 
the body is neutralised. 
First thing to do is to remove contaminated clothes and wash off pesticides from 
the body. If the patient is awake, gastric lavage is  given. For unconscious 
patients, endotracheal intubation should be given prior to gastric lavage and is 
more beneficial if the patient arrives early after consumption.48 If it is done within 
20 min, absorption decreases by 42% and in 60 minutes, absorption decreases by 
16%. 49 WHO recommends gastric lavage after basic stabilisation of the patient 
Activated charcoal can also be used to decrease absorption. 
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Figure 8 : TREATMENT PROTOCOL FOR OP POISONED PATIENTS  
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 Initial phase: 
Adequate airway, breathing and circulation should be maintained. The patient 
should be made to lie down in the left lateral position for patent airway, to 
decrease aspiration and to decrease absorption.50  Administer oxygen if 
respiratory distress is present. Patient should be maintained in nil oral condition 
for 24 hours as increasing the oral fluid will increase the rate of absorption. 
Maintenance phase: 
 The excess accumulation of Ach is neutralised by anticholinergic drugs like 
atropine. Initial dose of atropine 1-3 mg (0.05mg/kg) is given I.V slowly over 3 
min. Atropine cures muscarinic effects of OPC poisoning. 51 Repeat atropine  in 
3-5 min even as double dosage  infusion until signs of atropinisation like clear 
lung fields, mid pupil position, heart rate > 110/min, SBP> 90mmHg, bowel 
sounds, dryness of nose& mouth are achieved.52  In children, 0.015-0.05 mg/kg 
atropine I.V should be administered every 15 min based on the patient’s status. 
Continuous infusion is used in very severe poisoning. Dosage can be reduced 
when the patient become stable at least for 6 hours. Then patient should be 
monitored for next 72 hours and look for any signs of relapse. Atropinisation 
should be given, if symptoms recur. Side effects of atropine are tachycardia, 
dryness, mydriasis, delirium and even paralysis.53 Stop the atropine if the patient 
develops fever, altered sensorium and muscle fibrillation.  
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Glycopyrrolate is administered in cases of severe respiratory distress or atropine 
toxicity.7.5 mg glycopyrolate in 200ml NS infusion is given till the patient have 
heart rate more than  60/min, absent fasciculations and dry mucous membrane.54 
Enzyme activity is to be reactivated within 10 min to get the best results. This is 
made possible by oximes. Oximes are preferably administered within 48 hours 
for good results. 
There are two types of oximes: 
1) Monopyridinium-Eg: Pralidoxime 
2) Bispyridinium- Eg :Trimedoxime and Obidoxime 
Chloride and iodide salts of pralidoxime is commonly used. The reversal of 
enzyme inhibition varies with the pesticide to which the patient is exposed. 
Oximes are not useful in patients with aspiration pneumonia/brain damage due to 
reduced oxygenation. But according to WHO, every patient who are given 
atropine should also be given oxime.55  In adults, it is given as 500mg/hour 
infusion continuously or 30mg/kg over 4-6 hours or 8-10mg/kg/hr I.V till the 
patient recovers fully. In children, pralidoxime 25mg/kg I.V should be given over 
15-30 minutes followed by infusion of 10-20mg/kg/hour. 56 Pralidoxime should 
not be given rapidly as bolus as it can cause aspiration, tachycardia or diastolic 
hypertension. Under bispyridinium group, obidoxime can cause hepatotoxic 
effects, nausea, pallor, headache, paraesthesia of face and generalised weakness. 
36 
 
Asoxime is given for nerve agent poisonings. They are used in combination with 
atropine and diazepam. 
Sometimes OP compound poisoned patient can develop delirium or seizures due 
to hypoxia, atropine toxicity, alcohol ingestion or other medical complications. 
Diazepam about 3-10 mg IV is given for these patients.  
Butryl choline esterase present in FFP can bind to OP compound and decrease 
plasma concentration of it.  Moreover it can balance the proteins and ions in the 
blood. But FFP is contraindicated for intermediate syndrome and patients on 
ventilator. It can even adversely affect the hospital stay and sometimes accelerate 
the death. 
Final Phase:  
Patients will recover from the toxic effect in this phase and needs only 
symptomatic treatment. 
MANAGEMENT OF COMPLICATIONS: 
If the patient goes for respiratory failure, endotracheal intubation and mechanical 
ventilation may be needed. Injection frusemide 40mg-80 mg IV should be given 
for pulmonary oedema. If patient develops heart blocks, temporary pacing may 
be needed.5-10mg of IV diazepam is given for patients with seizures.35 
Antibiotics and chest physiotherapy is mandatory for bronchopneumonia. 
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For intermediate syndrome supportive management is enough. For 
Organophosphate Induced delayed polyneuropathy, neuroprotective drugs and 
corticosteroids are given. Protease inhibitors can protect the neuronal target 
esterase, according to some studies. 
RECENT ADVANCES IN MANAGEMENT 
There are certain new drugs and methods for OP compound poisoning 
management. Calcium channel blocking magnesium sulphate reduces acetyl 
choline release and thus can easily manage the hyperstimulation. Alpha 2 agonist 
clonidine also decreases acetyl choline synthesis and release.57 Sodium 
bicarbonate can be used instead of oximes as it also helps in the correction of 
acidosis especially for nerve agent poisoning. It decreases the mortality rate and 
is given as infusion of  5 meq/kg in 60 minutes followed by 5-6 meq /kg/day. 
Organophosphate compounds can be removed from blood using haemodialysis 
and hemofiltration. 58  Even butyrl choline esterase acts on OP compounds and 
reduce the impact on acetyl choline esterase. The same principle works with 
recombinant bacterial phosphotriesterase or hydrolases and thus they reduce the 
OP concentration in blood. Phosphotriesterases are used to detoxify OPs. Anti-
oxidants can be used to decrease OP toxicity by increasing glutathione synthesis 
and decreasing the oxidative stress. Vitamin C and vitamin E, melatonin, 
spintraps can be used for the same. 
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PREVENTION 
Most of the insecticide poisoning are mainly due to organophosphorous 
compounds. This is of great concern in an agricultural country like India where 
pesticides are widely used. As occupational exposure is very common, individual 
protection equipments should be given which includes face masks and protective 
clothing. 59 These toxic pesticides should not be used for indoor uses and should 
be used only when there is sufficient air circulation. They should be used 
according to the customer instructions and labels on the bottle. Awareness about 
the poisoning should be given to the public and they should be trained to take 
emergency resuscitation measures. We should be careful that the poison is kept 
out of reach from children and people should be advised to use gloves while 
handling the poisons.60 All vegetables and fruits should be washed well before 
consumption. Physostigmine and pyridostigmine acts as reversible choline 
esterase inhibitors and can used as nerve agent poison prophylaxis at about 30 mg 
three times a day. 
“An ounce of prevention is worth a pound of cure.”  Proper awareness, proper 
handling, proper usage and proper disposal can help in preventing poisonings to 
a certain extent.  
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REVIEW OF PREVIOUS STUDIES 
The study conducted by Kavya et al 61 in 2012 taking 64 patients showed that 
there is a significant relationship between high POP score and low  
pseudocholinesterase level with  the need for ventilator support in the OP 
poisoned patient. 
Raghu H et al 62 found that clinical and biochemical parameters have a great role 
in predicting the need of ventilator support for OP poisoned patients. The 
parameters associated with bad prognosis as assessed by this study are: 
i. Greater time delay from intake of poison to get proper treatment 
ii. Low level of pseudocholinesterase 
iii. Low GCS score 
iv. Initial treatment with large dose of atropine. 
In a study conducted among 50 patients by Mahadeshwara Prasad et al 64, role of  
serum potassium and morbidity and mortality in OP poison was analysed .They 
found that OP poisoned patients who developed hypokalemia started showing 
signs like muscle fasciculation, convulsion, respiratory distress finally 
culminating  in death in a significant proportion . 
D.R.Moorthy et al 64 observed in a study among 50 patients that hypokalemia and 
reduced PchE are danger signs in OP poisoned patients as most of the patients 
with these features developed respiratory failure. 
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A study conducted at H.S.K hospital by Subhash et al65  found that 
hyperamylasemia in severely poisoned patient directly correlates with 
mechanical ventilator support. They observed that there is a strong association 
between clinical and lab parameters like POP scale, serum amylase level and 
serum cholinesterase level and the need of ventilator. 
Sumathi et al 66 conducted another similar study, has got same inference like 
subhash et al- hyperamylasemia is strongly associated with severity of OP 
poisoning. But they also showed that  serum lipase and CPK can also be used as 
predictive markers  of OP poisoning . 
In Korea, Eun-Jung Kang et al 67 conducted a study about survival determining 
factors in acute organophosphate poisoning and found that APACHE II score  
correlated  more with serum cholinesterase level and is a good prognostic 
indicator in acute organophosphate poisoning. 
Eddelston et al 68 has conducted a study about predictive outcome in acute 
organphosphorous poisoning and found that poison severity score is one of the 
useful indices to know the outcome of OP poisoned patients and the study also 
showed that GCS ≤ 13 needs intensive monitoring. They have shown that GCS is 
a good prognostic marker in OP poisoning. 
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Tzeng-Jih Lin et al 69 conducted a study in Taiwan to know the prognostic 
indicators in death and survival groups. They found out that low levels of acetyl 
choline esterase and plasma cholinesterase is associated with increased rate of 
death.  
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                                MATERIALS AND METHODS 
 
STUDY DESIGN: 
 
 This is a prospective and observational study of 50 cases of organophosphorous 
compound poisoning admitted in Government Mohan Kumaramangalam medical 
college hospital, Salem during the period of June 2015 to June 2016(one year) 
 
INCLUSION CRITERIA: 
 
1. Patients with organophosphorous compound poisoning above the age of      
12 years 
2. Patients with history of exposure to a single organophosphorous 
compound  
3. Patients with history of exposure to organophosphorous compound within 
previous 24 hours 
 
EXCLUSION CRITERIA: 
 
       1. Patients below the age of 12 years 
        2. Patients with history of exposure to multiple compounds 
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        3. Patients with history of neuromuscular junction disorders 
        4. Patients with chronic lung disease 
        5. Patients treated outside for poisoning 
        6. Patients presented 24 hours after the consumption of poison 
 
METHOD OF COLLECTION OF DATA: 
 
  Fifty patients with organophosphorous compound poisoning admitted in 
Government Mohan Kumaramangalam medical college hospital, Salem were 
studied. Information was gathered through a prepared proforma which was 
specifically designed for the study. A provisional diagnosis of 
organophosphorous compound poisoning was made on the basis of definite 
history of poisoning given either by the patient or the patient’s attendants which 
was substantiated by examination of container or typical clinical features such as 
excessive secretions ,miosis, fasciculations or characteristic odour of stomach 
wash and or vomitus. 
 Each patient enrolled in the study underwent a detailed clinical examination with 
particular reference to vital signs , assessment of central nervous system, 
respiratory system and cardiovascular system. This examination was carried out 
at the initial presentation in the emergency room and the cases were followed up 
during their ward/ICU stay. Peradeniya OP poisoning scale was applied to each 
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patient at the time of admission and the severity of the poisoning was graded as 
mild (POPS score 0-3) , moderate (POPS score 4-7) ,severe (POPS score 8-11). 
  5ml of blood was collected at the time admission, before initiation of treatment 
and the samples were sent for estimation of serum pseudocholinesterase and 
serum potassium apart from other routine investigations. Reference range for 
serum pseudocholinesterase in the lab was 4260-12920 IU/L.A 
pseudocholinesterase activity of 40-60% of normal constituted mild poisoning, 
between 20-40% was taken as moderate poisoning and values less than 20% was 
considered as severe poisoning. The reference range for serum potassium was 
3.5-5.5 mEq/l. 
 During their follow up in ward/ICU , each patient was closely monitored and 
ventilator support was considered in patients with apnoea or hypoventilation, 
persistent cyanosis, persistent tachypnoea and deranged oxygen saturation. Total 
dose of atropine given for the treatment was also calculated. 
  Above mentioned clinical parameters (as assessed by Peradeniya OP poisoning 
scale) and biochemical parameters were studied for their prognostic value in 
assessing the severity of organophosphorous compound poisoning predicted in 
terms of need for mechanical ventilation , total dose of atropine needed and final 
clinical outcome. 
 Data was tabulated in Microsoft Excel and was analysed using SPSS software. 
Pearson chi square test, student’s T-test and ANOVA test were used to analyse 
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the data.By using these tests statistical significance was calculated. A ‘p value’ 
of less than 0.01 was taken as statistically highly significant and a ‘p value’ of 
less than 0.05 was taken as significant   
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                 OBSERVATIONS AND RESULTS 
 
The results of this study are as follows 
1. Distribution of the patients according to age 
                                Table-7:Age distribution of the patients. 
 
 
 
 
 
 
 
                          Figure-9: Bar diagram showing age distribution 
 
 
In this study, maximum number of patients were below 20 years (32%), followed 
by 18% of patients in the age group 41-50 years. The youngest patient was 13 
Upto 20 yrs 21 - 30 yrs 31 - 40 yrs 41 - 50 yrs 51 - 60 yrs Above 60
yrs
16
6
8
9
7
4
AGE RANGE
Age Group Frequency Percentage 
 Upto 20 16 32.0 
21 - 30 6 12.0 
31 - 40 8 16.0 
41 - 50 9 18.0 
51 - 60 7 14.0 
Above 60 4 8.0 
Total 50 100.0 
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years of age and oldest patient in this study was 74 years of age. Patients above 
60 years constituted only 8% of the study population 
 
2. Distribution of the patients according to gender 
   
                              Table-8: Sex distribution of the patients 
Sex Frequency Percentage 
 Female 14 28.0 
Male 36 72.0 
Total 50 100.0 
 
Figure-10 : Pie chart showing sex distribution 
 
Out of the 50 cases, 36 were males (72%) and 14 were females (28%).Male to 
female ratio was 2.57:1 
 
 
3. Distribution of the patients according to occupation 
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Table- 9: Distribution of the patients according to the occupation 
OCCUPATION FREQUENCY PERCENTAGE 
 Agriculture 
Labourer 
23 46.0 
Construction 
Worker 
1 2.0 
Hotel Worker 1 2.0 
House Wife 3 6.0 
Sales 
Executive 
1 2.0 
Sales Girl 1 2.0 
Shop Keeper 1 2.0 
Student 13 26.0 
Teacher 2 4.0 
Unemployed 1 2.0 
Weaver 2 4.0 
Work Shop 
Employee 
1 2.0 
Total 50 100.0 
 
Figure-11:Bar diagram showing occupational distribution 
 
0 5
10
15
20
25
A G R I C U L T U R E  L A B O U R E R
C O N S T R U C T I O N  W O R K E R
H O T E L  W O R K E R
H O U S E  W I F E
S A L E S  E X E C U T I V E
S A L E S  G I R L
S H O P  K E E P E R
S T U D E N T
T E A C H E R
U N E M P L O Y E D
W E A V E R
W O R K  S H O P  E M P L O Y E E
OCCUPATION
49 
 
46% of the patients were agricultural labourers and 26% of the patients were 
teachers and weavers were 4% each. No patients were present from the higher 
strata of society. 
4. Distribution of the patients according to intention of poisoning 
 Table-10:Distribution of the patients according of intention of poisoning 
INTENTION FREQUENCY PERCENTAGE 
 Accidental 2 4.0 
Suicidal 48 96.0 
Total 50 100.0 
 
Figure-12:Pie chart showing intention of poisoning 
 
 
Majority of the patients consumed poison with intention of suicide (96%). Only 
two patients (4%) were having accidental exposure to poison. No homicidal 
intention was present in the study group. 
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5. Distribution of the patients according to compound consumed 
Table-11:Frequency table of compound used 
COMPOUND FREQUENCY PERCENTAGE 
 Chlorpyrifos 7 14.0 
Diazinon 2 4.0 
Dichlorfos 5 10.0 
Difenofos 2 4.0 
Malathion 5 10.0 
Monocrotophos 14 28.0 
Phorate 6 12.0 
Profenofos 7 14.0 
Quinolfos 2 4.0 
Total 50 100.0 
 
Figure-13:Bar diagram showing frequency distribution of compound used 
 
 
The compounds consumed by the patients included 9 different organ phosphorous 
chemicals.14 patients (28% of study population) took monocrotophos. The 
second most common compounds consumed were chlorpyrifos and 
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profenofos(14% each). The next most common compound used was 
phorate(12%) 
6. Distribution of the patients according to delay in admission to hospital 
Table -12:Distribution of patients according to delay in admission 
DELAY IN 
ADMISSION 
(HOURS) FREQUENCY PERCENTAGE 
 2 10 20.0 
3 12 24.0 
4 14 28.0 
5 9 18.0 
6 5 10.0 
Total 50 100.0 
  
Figure-14: Bar diagram showing delay in admission of patients 
 
The study group included only those patients who presented within 24 hours of 
consumption of poison. Majority of the patients (72%) presented within 4hours 
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of consumption of poison. Delay in admission was about 6 hours in 10% of the 
patients. Mean delay in admission was 3.7 hours. 
7. Distribution of the patients according to presenting symptom 
Table-13:Frequency of symptoms 
 
Figure-15: Bar diagram showing frequency of symptoms 
 
The commonest symptom found was vomiting (94%), followed by excessive 
secretions (84%). 70% of the patients had breathlessness and 28% of the patients 
had diarrhoea. Loss of consciousness and seizures were relatively uncommon 
presentation and was reported by 22% and 12% of the patients respectively. 
       SYMPTOM No.of patients Percentage
Breathlessness 35 70
Excessive secretions 42 84
Vomiting 47 94
Diarrhoea 14 28
Loss of consciousness 11 22
Seizures 6 12
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8. Distribution of the patients according to POP scale score 
Table-14: Frequency distribution according to POPS score 
POPS  SCORE FREQUENCY PERCENTAGE 
 0 1 2.0 
1 9 18.0 
2 3 6.0 
3 5 10.0 
4 2 4.0 
5 5 10.0 
6 4 8.0 
7 2 4.0 
8 14 28.0 
9 3 6.0 
10 
11 
2 
0 
4.0 
0.0 
Total 50 100.0 
 
Figure-16 : Bar diagram showing frequency distribution of POP score 
 
28% of the patients had a POP scale score of 8.18% of the patients had a score of 
1. A POP scale score of 3 and 5 were present in 10% each of the patients. One 
patient had a POP scale score of 0 while none of the patients had full score of 11. 
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9. Distribution of the patients according to severity of poisoning as assessed 
by    POPS scale  
Table-15:Frequency distribution according to POPS severity. 
 
Figure-17: Pie chart of POPS severity 
 
 
38% of the patients had severe poisoning according to POP scale.36% had mild 
poisoning and 26% of the patients had moderate poisoning. 
 
10. Distribution of the patients according to severity of pseudo cholinesterase 
reduction 
 
 
POP SCALE No. of patients Percentage Percentage
MILD (SCORE 0-3) 18 36
MODERATE (SCORE 4-7) 13 26
SEVERE (SCORE 8-11) 19 38
36%
26%
38%
SEVERITY OF POISONING
MILD MODERATE SEVERE
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Table-16: Frequency distribution according to pseudochE reduction 
 
PSEUDOCHOLINESTERASE 
REDUCTION 
NO. OF 
PATIENTS 
PERCENTAGE 
MILD 20 40 
MODERATE 14 28 
SEVERE 16 32 
 
Figure-18:Doughnut showing pseudochE reduction 
 
 
40% of the patients had mild reduction in pseudo cholinesterase activity.28% of 
the patients had moderate reduction and 32% had severe reduction in pseudo 
cholinesterase activity. 
 
11. Distribution of the patients according to serum potassium levels 
           Table-17: Distribution of the patients according to serum potassium level 
SERUM 
POTASSIUM 
NO. OF 
PATIENTS 
PERCENTAGE 
Hypokalemia 6 14 
Normokalemia 44 86 
Hyperkalemia 0 0 
40%
28%
32%
PSEUDOCHOLINESTERASE 
REDUCTION
MILD MODERATE SEVERE
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Figure-19: Bar diagram showing distribution of the patients according to serum 
potassium level 
 
 
14% of the study population had hypokalaemia at the time of presentation. In rest 
of the patients, serum potassium levels were normal. 
12. Distribution of the patients according to need for ventilator support 
Table-18:Frequency distribution of ventilator support 
VENTILATOR 
SUPPORT 
FREQUENCY PERCENTAGE 
Not needed 21 42.0 
Needed 29 58.0 
Total 50 100.0 
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Figure-20: Pie chart showing ventilator support 
 
58% of the patients required ventilator support.42% of the patients didn’t require 
ventilator support 
13. Distribution of the patients according to clinical outcome 
Table-19: Distribution of patients according to outcome 
OUTCOME FREQUENCY PERCENTAGE 
Died 9 18.0 
Improved 41 82.0 
Total 50 100.0 
 
Figure-21: Pie chart showing clinical outcome 
 
Of the 50 patients enrolled in the study, 41 patients (82%) improved.9 patients 
died due to various complications 
14. Distribution of the patients who died according to the cause of death 
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Table-20:Frequency distribution of cause of death 
CAUSE OF 
DEATH 
NO. OF 
PATIENTS 
PERCENTAGE 
VAP 3 33.33 
IMS 6 66.66 
 
 
Figure-22:Pie chart showing distribution of cause of death 
.                    0 
Of the 9 deaths, 6 deaths were due to intermediate syndrome and 3 deaths were 
due to ventilator associated pneumonia. 
 
15. Association between individual parameters of Peradeniya OP poisoning 
scale and need for ventilator support 
Table-21: Association between Individual parameters of POPS and clinical 
outcome  
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POP     PARAMETER Ventilator 
Support 
Total Chi 
square 
Likelihood 
ratio 
p 
value 
No Yes 
   
 
 
 Miosis 
0 Count 3 0 3  
 
 
23.248 
 
 
 
26.117 
 
 
 
0.005 
Percent 100.0 0.0 100.0 
1 Count 11 1 12 
Percent 91.7 8.3 100.0 
2 Count 7 28 35 
Percent 20.0 80.0 100.0 
Fasciculations 0 Count 18 3 21  
 
 
29.768 
 
 
 
36.256 
 
 
 
0.005 
Percent 85.7 14.3 100.0 
1 Count 3 11 14 
Percent 21.4 78.6 100.0 
2 Count 0 15 15 
Percent 0.0 100.0 100.0 
Respiratory 
rate 
0 Count 10 0 10  
 
 
17.915 
 
 
 
22.302 
 
 
 
0.005 
Percent 100.0 0.0 100.0 
1 Count 11 27 38 
Percent 28.9 71.1 100.0 
2 Count 0 2 2 
Percent 0.0 100.0 100.0 
Pulse rate 0 Count 15 1 16  
 
 
28.238 
 
 
 
34.766 
 
 
 
0.005 
Percent 93.8 6.3 100.0 
1 Count 6 16 22 
Percent 27.3 72.7 100.0 
2 Count 0 12 12 
Percent 0.0 100.0 100.0 
Level of 
consciousness 
0 Count 19 4 23  
 
 
28.834 
 
 
 
32.52 
 
 
 
0.005 
Percent 82.6 17.4 100.0 
1 Count 1 13 14 
Percent 7.1 92.9 100.0 
2 Count 1 12 13 
Percent 7.7 92.3 100.0 
Seizures 0 Count 21 24 45  
4.023 
 
5.846 
 
0.045 Percent 46.7 53.3 100.0 
1 Count 0 5 5 
Percent 0.0 100.0 100.0 
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The table shows comparisons of individual components of POP scale in 
predicting the need for ventilator support 
 In patients with no miosis (pupillary size>2mm), none required ventilator 
support. In those patients with miosis score of 1, 8.3% required ventilator support. 
In patients with pinpoint pupil 80 % required ventilator support which has high 
statistical significance (p value 0.005) 
In patients with no fasciculations  , 14.3 % required ventilator assistance. But in 
those with fasciculation score 1 and 2, the percentage of patients requiring 
ventilator support was 78.6 % and 100% respectively. These results were 
statistically highly significant (p value 0.005 ). 
Those patients who were having respiratory rate < 20 /minute did not require 
ventilator support. But 71.1 % of patients with respiratory rate > 20/minute and 
100 % of the patients with cyanosis at the time of admission required ventilator 
assistance. This relation was found statistically highly significant (p value 0.005). 
In patients with pulse rate > 60 /minute, 6.3 % required ventilator support. 72.7 
% of the patients with pulse rate 41 – 60 / minute and 100 % of the patients with 
< 40/ minute needed ventilator support. It was statistically highly significant (p 
value 0.005). 
In conscious patients 17.4 % of the patients needed ventilator assistance .In 
patients with impaired level of consciousness 92.9 % required ventilator 
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support.92.3 % of the patients in stuporous state were connected to the ventilator. 
These results were found to be statistically highly significant (p value 0.005). 
Of the 50 patients in the study group 5 developed seizures and all those patients 
needed ventilator assistance. It was statistically significant with a p value of 0.005 
16. Association between POP scale score and need for ventilator support 
TABLE -22: Association between POP  score and need for ventilator support 
POPS Severity Ventilator 
Support 
Total Chi 
square 
Likelihood 
ratio 
p 
value 
No Yes 
Mild Count 17 1 18  
 
 
34.755 
 
 
 
44.257 
 
 
 
0.005 
percent 94.4 5.6 100.0 
Moderate Count 4 9 13 
percent 30.8 69.2 100.0 
Severe count 0 19 19 
percent 0.0 100.0 100.0 
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Figure –23:Bar diagram showing POPS severity and ventilatory support 
 
 
Only 5.6 % of the patients with mild grade of poisoning required ventilator 
support but 69.2 % of patients with moderate grade of poisoning and 100 % of 
patients with severe grade of poisoning required ventilator assistance. This was 
statistically highly significant (p value 0.005) 
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17. Association between POP scale score and dose of atropine needed 
 
Table –23: Association between POP scale score and dose of atropine needed 
Severity No: of 
patients 
Mean dose of 
Atropine 
Standard 
Deviation 
Standard 
Error 
Mild 18 176.78 117.217 27.628 
Moderate 13 452.15 97.079 26.925 
Severe 19 480.63 47.912 10.992 
Total 50 363.84 167.722 23.720 
 
Figure –24:Bar diagram showing dose of atropine and POPS 
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   Mean dose of atropine needed for treatment in patients with mild poisoning was 
176.78 mg. In moderate grade of poisoning mean dose of atropine used was 
452.15 mg and in severe grade poisoning, mean dose of atropine 480.63 mgs. 
When analysed by ANOVA test these associations were found to be statistically 
highly significant 
18. Association between POP scale score and serum pseudocholine esterase     
level 
Table –24:Association between POP  score and serum pseudocholine esterase     
level 
 
SEVERITY NO: OF 
PATIENTS 
MEAN PSEUDO 
CHE 
STANDARD 
DEVIATION 
STANDARD 
ERROR 
Mild 18 4962.22 1634.710 385.305 
Moderate 13 1570.46 1257.641 348.807 
Severe 19 642.37 369.904 84.862 
Total 50 2438.82 2270.520 321.100 
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Figure –25:Bar diagram showing POPS score and serum pseudocholinesterase 
 
 
Mean pseudocholinesterase levels in those patients with mild grade of poisoning 
was 4962.22.In moderate grade poisoning, mean value was 1570.46.In severe 
poisoning mean value fell down to 642.37.When these associations were 
submitted to statistical analysis by ANOVA test, it was found to be statistically 
significant with p value of 0.005. 
 
19.Association between serum pseudocholinesterase level and need for 
ventilatory support 
Table-25: Association between serum pseudocholinesterase level and need for 
ventilatory support 
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Pseudo chE 
reduction 
Ventilator 
Support 
Total Chi 
square 
Likelihood 
ratio 
p 
value 
No Yes 
Mild Count 18 2 20  
 
 
32.935 
 
 
 
40.478 
 
 
 
0.005 
Percent 90.0% 10.0% 100.0% 
Moderate Count 3 11 14 
Percent 21.4% 78.6% 100.0% 
Severe Count 0 16 16 
Percent 0.0% 100.0% 100.0% 
 
Figure-26:Bar diagram showing relation between pseudochE and ventilator 
support 
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Of the 20 patients with mild reduction in pseudocholinesterase activity,only 2 
(10%) required ventilator support.There were 14 patients with moderate 
reduction in serum pseudocholinesterase activity. Of these,11(78.6%) required 
ventilator support.16 patients had severe reduction in pseudocholinesterase.all 
those patients(100%) ended up in ventilator support.The p value for this 
association was calculated as 0.005,which was highly significant.  
20.Association between serum pseudocholinesterase level and dose of 
atropine needed 
Table-26: Association between serum pseudocholinesterase level and dose of 
atropine needed 
PSEUDO CHE 
REDUCTION 
NO.OF 
PATIENTS 
MEAN DOSE 
OF ATROPINE 
STANDARD 
DEVIATION 
STANDARD 
ERROR 
Mild 20 190.90 124.825 27.912 
Moderate 14 481.57 66.157 17.681 
Severe 16 497.00 43.488 10.872 
Total 50 363.84 167.722 23.720 
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Figure-27:Bar diagram showing pseudocholinesterase and mean dose of atropine 
 
Mean dose of atropine used in the treatment of mild reduction was 190.90mg. 
Mean dose was higher in patients with moderate and severe reductions in 
pseudocholinesterase (481.57 and 497 mg respectively). When analysed by 
ANOVA test,these associations were found to be statistically highly significant 
within groups( p value 0.005). 
21. Association between total dose of atropine used and ventilator support 
Table-27:Association between total dose of atropine used and ventilator support 
Ventilator 
support 
No.of 
patients 
Mean dose 
of atropine 
Standard 
Deviation 
standard 
error 
T-test p value 
Not 
required 
21 200.10 129.201 28.194  
-10.692 
 
0.005 
Required 29 482.41 51.324 9.531 
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Figure-28:Bar diagram showing relation between dose of atropine and ventilator 
support 
 
Of the 50 patients studied,29 required ventilator support.Mean dose of atropine 
used in this group was 482.41mg. In those patients who didn’t require 
ventilator,mean dose of atropine was 200.10mg.By T-test, this association was 
found to be highly significant statistically (p value 0.005). 
 
 
22. Association between delay in admission and need for ventilator support 
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Table-28: Association between delay in admission and need for ventilator support 
Ventilator 
support 
No.of 
patients 
Mean delay 
in admission 
Standard 
deviation 
Standard 
error 
T-test p 
value 
NOT 
REQUIRED 
21 3.95 1.532 0.334  
1.016 
 
0.347 
REQUIRED 29 3.59 1.018 0.189 
  
FIGURE-29:Bar diagram showing relation between delayed admission and 
ventilator support. 
 
The mean delay in admission of ventilator required patients was 3.59 hours, while 
of non ventilator patients was 3.95 hours. When analysed by T-test ,this 
association was found to be statistically non significant(p value 0.347) 
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.23. Association between compound consumed and need for ventilator 
support 
Table-29: Association between compound consumed and need for ventilator support 
COMPOUND Ventilator 
Support 
Total Chi 
square 
Likelihood 
ratio 
p 
value 
No Yes 
CHLORPYRIFOS Count 2 5 7  
 
 
 
 
 
 
27.950 
 
 
 
 
 
 
 
35.111 
 
 
 
 
 
 
 
0.005 
Percent 28.6 71.4 100.0 
DIAZINON Count 2 0 2 
Percent 100. 0.0 100.0 
DICHLORFOS Count 4 1 5 
Percent 80.0 20.0 100.0 
DIFENOFOS Count 1 1 2 
Percent 50.0 50.0 100.0 
MALATHION Count 5 0 5 
Percent 100. 0.0 100.0 
MONOCROTOPHOS Count 1 13 14 
Percent 7.1 92.9 100.0 
PHORATE Count 0 6 6 
Percent 0.0 100. 100.0 
PROFENOFOS Count 4 3 7 
Percent 57.1 42.9 100.0 
QUINOLFOS Count 2 0 2 
Percent 100. 0.0 100.0 
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FIGURE-30:Bar diagram showing compound consumed and ventilator support 
 
 
100% of the patients who took phorate needed ventilator support.92.9% of the 
patients with monocrotophos poisoning required ventilator support.71.4% of the 
patients with chlorpyrifos poisoning needed ventilator assistance.When analysed 
by Pearson Chi square test, this association was found to be statistically 
significant(p value 0.005). 
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24.Association between compound consumed and clinical outcome 
Table-30 :Association between compound consumed and clinical outcome 
           COMPOUND             Outcome Chi 
square 
  Likelihood    
ratio 
  p 
value DIED IMPROVED 
CHLORPYRIFOS Count 1 6  
 
 
 
 
 
 
 
 
8.382 
 
 
 
 
 
 
 
 
 
10.156 
 
 
 
 
 
 
 
 
 
0.397 
Percent 14.3 85.7 
DIAZINON Count 0 2 
Percent 0.0 100.0 
DICHLORFOS Count 0 5 
Percent 0.0 100.0 
DIFENOFOS Count 0 2 
Percent 0.0 100.0 
MALATHION Count 0 5 
Percent 0.0 100.0 
MONOCROTOPHO
S 
Count 3 11 
Percent 21.4 78.6 
PHORATE Count 3 3 
Percent 50.0 50.0 
PROFENOFOS Count 2 5 
Percent 28.6 71.4 
QUINOLFOS Count 0 2 
Percent 0.0 100.0 
 
 
 
74 
 
Figure-31: Bar diagram showing compound consumed and clinical outcome 
 
50% of the patients who consumed phorate died. Mortality was 28.6% and 21.4% 
respectively in those patients who consumed profenofos and monocrotophos 
respectively. When the compounds consumed and clinical outcome were 
subjected to statistical analysis, the association was not found to be significant(p 
value 0.397) 
25.Association between POP scale score and clinical outcome 
 
Table-31:POPS score and clinical outcome 
POPS SCALE OUTCOME Chi 
square 
Likelihood 
ratio 
p 
value DIED IMPROVED 
Mild Count 0 18  
 
8.582 
 
 
10.969 
 
 
0.014 
Percent 0.0 100.0 
Moderate Count 2 11 
Percent 15.4 84.6 
Severe Count 7 12 
Percent 36.8 63.2 
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Figure-32:Bar diagram showing POPS score and clinical outcome 
 
All the patients with mild grade poisoning in POPS scale improved. Mortality 
rate was 15.4% in moderate grade poisoning and 36.8% in severe poisoning. This 
association was found to be statistically significant. 
26.Association between severity of pseudocholinesterase reduction and   
clinical outcome 
Table-32:Association between pseudochE and clinical outcome 
PseudochE 
reduction 
          Outcome Chi 
square 
Likelihood ratio p value 
DIED IMPROVED 
Mild Count 0 20  
 
 
8.624 
 
 
 
11.421 
 
 
 
0.013 
Percent 0.0 100.0 
Moderate Count 3 11 
Percent 21.4 78.6 
Severe Count 6 10 
Percent 37.5 62.5 
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Figure-33:Bar diagram showing pseudochE and clinical outcome 
 
All the patients with mild reduction in pseudocholinesterase activity 
improved.21.4% of the patients with moderate reduction  and 37.5% of the 
patients with severe reduction died,which when analysed by Pearson Chi square 
test was found to be significant with a p value of 0.013.  
27.Association between POP scale score and mean duration of treatment 
Table-33: POPS score and mean duration of treatment 
POPS 
GRADE 
No. of   
patients 
Mean 
duration of 
treatment 
Standard 
Deviation 
Standard 
error 
Mild 18 5.11 1.023 0.241 
Moderate 13 8.62 3.042 0.844 
Severe 19 8.84 3.114 0.714 
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Figure-34:Bar diagram showing POPS score and mean duration of treatment 
 
Mean duration of treatment in mild grade poisoning was 5.11 days. It was 8.62 
days for moderate grade poisoning and 8.84 days for severe poisoning. When 
analysed by ANOVA test,these associations were found to be statistically highly 
significant between the groups( p value 0.005). 
28.Association between serum potassium and need for ventilator support 
 Table- 34A:Serum potassium and ventilator support 
Serum Potassium Ventilatory 
Support 
Chi 
square 
Likelihood 
ratio 
p value 
No Yes 
Normal Count 21 23  
 
4.937 
 
 
7.123 
 
 
0.026 
Percent 47.7 52.3 
Abnormal Count 0 6 
Percent 0.0 100.0 
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of the 44 normokalemic patients,23(52.3%) required ventilator support.6 patients 
had hypokalemia at the time of presentation and all needed ventilator support later 
in the treatment. This association was found to be statistically significant. 
Table-34B:Mean serum potassium and ventilator support 
Ventilatory 
support 
No. of patients Mean serum 
potassium 
Standard 
deviation 
Standard 
Error 
T-test p value 
Not required 21 4.014 0.2151 0.0469  
3.465 
 
0.001 Required 29 3.731 0.3263 0.0606 
 
Mean serum potassium in ventilator required patients was 3.731 and in others was 
4.014. when this was subjected to analysis by T-test,association was found to be 
statistically highly significant(p value 0.001) when equal variances were 
assumed. 
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DISCUSSION 
Organophosphorous compound poisoning is a common health problem in third 
world countries. The major cause of morbidity and mortality in OP poisoning is 
respiratory failure and patients may require ventilator support & ICU care. But in 
developing nations like India, where ICU facility may not be readily available 
because of limited resources and patient load, stratification of patients carrying 
high risk of developing respiratory failure and intense monitoring of those 
patients, play a crucial role in reducing mortality. The study was undertaken to 
assess the prognostic significance of such clinical and biochemical parameters in 
predicting the clinical outcome in OPC poisoning. 
In our study, majority of the patients were below 20 years of age (32%), followed 
by 18% of patients in the age group of 41-50 years. Studies done by Goel et al, 70 
Reihman et al 71 and Kavya et 61 al have shown that OPC poisoning is common in 
the age group of 21-30 years. The predominance in young adults reflects the 
emotional conflicts that are prevalent in this age group. 
Majority of the patients in the study group were males (72%). The male to female 
ratio is 2.57:1. Similar male preponderance was observed by Goel et al70 , Kavya 
et al61  and Rajeev H et al 72  also, in their studies. 
The study shows that majority of the patients who consumed poison were 
agricultural laborers (46%). This may be because of easy accessibility to 
pesticides in that group. 26% of the study group were students, which raises great 
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concern. Consumption of OP compounds was relatively uncommon in higher 
strata of the society. 
 Our study reveals that 96% of patients consumed poison with an intention of 
suicide and 4% were accidental exposures. OPC compounds are easily accessible 
pesticides and it may be the reason why it is used as a common mode of 
attempting suicide. These values correlate with observations made by Kozaic et 
al 73 (85%) and Goet et al70  (96.1%). 
  The most common compound consumed by patients was Monocrotophos (28%) 
followed by Chlorpyrifos and Profenofos. Study done by Subhash et al showed 
that most common compound used was Malathion and Rajeev H et al72  showed 
that it was Methyl Parathion. The compounds available may have regional 
variations according to local agriculture and economy. 
Most of the patients (72%) were admitted in the hospital within 4 hours of 
consumption of poison and mean delay was calculated as 3.7 hours. 
In the present study, commonest symptom encountered was vomiting (94%) 
followed by excessive secretions. Seizures was relatively uncommon and was 
present in only 12% of the study group. These observations are similar to the 
patterns by Rajeev H et al72  and Subhash et al .65  
 In our study, 36% of the patients had mild grade of poisoning according to POP 
scale score, 26% had moderate grade poisoning and 38% had severe poisoning. 
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Only 5.6% patients with mild grade of poisoning needed ventilator support, while 
100% patients with severe poisoning required ventilator assistance. This relation 
was statistically highly significant. When individual parameters of the POP scale 
namely miosis , fasciculations, respiratory rate, pulse rate, level of consciousness 
and seizures were compared with the  requirement of ventilator assistance, all 
carried a significant correlation. These observations were comparable to the 
studies done by Subahsh et al, Kavya et al. 
 In our study, POP scale score at the time of admission correlated well with 
pseudocholinesterase activity. Mean pseudocholinesterase level was 492.22IU/L 
in mild grade poisoning. It was 1570.46 and 642.37 respectively in moderate 
grade and severe grade poisoning. These results were statistically highly 
significant. Subhash et al and Kavya et al had made similar observations in their 
studies. 
All the patients with mild grade of poisoning according to POP scale improved. 
36.8% of the patients with severe poisoning expired. These observations were 
consistent with those made by Kavya et al and Subhash et al. Mean deviation of 
the treatment in mild grade poisoning was 5.11 days and in severe poisoning, it 
was 8.84 days. This relation was statistically significant. These findings were 
consistent with the observations made by Shabari Girish et al 74 and Kavya et al. 
In our study ,40% of the patients had mild reduction in peudocholinesterase 
levels, 28% had moderate reduction and 32% had severe reduction. 10% patients 
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with mild reduction and 100% patients with severe reduction needed ventilator 
assistance. Kavya et al has shown that 100% of the patients with severe reduction 
in pseudocholinesterase required ventilator support. Rajeev et al and Sunder Ram 
et al53  have also made similar observations. Manu et al has done a retrospective 
study demonstrating that low pseudocholinesterase level is associated with poor 
prognosis, mortality, longer ICU stay as well as a longer time to come out of 
mechanical ventilation. Studies done by Amanvermez R et al 75and Hundekari et 
al 76 had also demonstrated similar findings. 
 Study done by Eddleston et al has shown that different OPs inhibit 
pseudocholinesterase in varying degrees, when compared to their abilities to 
inhibit acetylcholinesterase. So they have warned that pseudocholinesterase 
activity does not always reflect severity. Active metabolite of Chlorpyrifos is a 
more potent inhibitor of pseudocholinesterase than acetyl cholinesterase, but 
Dimethoate has exactly opposite action, inhibiting acetyl cholinesterase more 
than pseudocholinesterase. So results of pseudocholinesterase activity should be 
interpreted keeping these patients in mind, although it can be taken as a good 
prognostic marker in our setting. 
When pseudocholinesterase levels at the time of admission were analysed in 
relation with clinical outcome, it was found that 37.5% of patients with severe 
reduction died and it was statistically significant. Similar observations were also 
made by Subhash et al, Ahmed et al 77 and Goswamy et al.78 
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  Mean dose of atropine needed for treatment in mild poisoning by POP scale 
score was 176.78mg, but patients with severe poisoning required a mean dose of 
480.63mg. This association was statistically highly significant. Study done by 
Shah Harsh et al has showed that as POP scale score increases, the dose of 
atropine needed for treatment also increases. Reihman et al 71  has also made 
similar observations. In patients with mild reduction in pseudocholinesterase, 
mean dose of atropine needed was 190.90mg, but patients with severe reduction 
required a much higher dose(497mg). These findings were similar to the pattern 
observed by Reihman et al and Subhash et al and is statistically and clinically 
significant. 
 
Mean dose of atropine used in patients requiring ventilator support was 
482.41mg, while in others, it was 200.10. There is a statistically significant 
positive correlation between the mean dose of atropine used for treatment and the 
need for ventilator support. Kozaic et al 73had earlier shown that higher dose of 
atropine is needed for treatment of patients with respiratory failure. Rajeev H et 
al has concluded that higher the initial dose of atropine needed for atropinisation 
, higher is the chance of respiratory failure. These observations also correlate well 
with the studies of Singh et al 54 and Subhash et al. 
  In our study, 86% of the patients had normal serum potassium levels and 14% 
had hypokalemia at the time of presentation.  D.R.Murthy et al 64 has shown that 
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hypokalemia is a frequent finding in OP poisoning. Even minor changes in serum 
potassium has deleterious effects on the RMP of electrically excitable cells. 
Hypokalemia manifests as muscle weakness, hyporeflexia and paralysis. 
Hypokalemia may aggravate OP induced respiratory muscle weakness. Murthy 
et al has proposed serum potassium at the time of admission as a predictive 
marker of ventilator support. 6 patients had hypokalemia at the time of 
presentation and all of them needed ventilator support. Mean serum potassium in 
ventilator requiring patients was 3.731 and in others was 4.014. These 
observations were found to be statistically significant. 
In our study, of the 50 patients, 58% of the patients required ventilator support . 
In a study done by Subhash et al, the percentage of patients requiring ventilator 
support was 27%. In a study done by Kavya et al, the percentage of patients 
requiring ventilator support was found to be 80%. 
  Of the 50 patients enrolled in our study, 41 patients (82%) improved and 9 
patients died due to various complications. The mortality rate was 18% . Study 
done by Kiran et al showed a mortality rate of 10% and another study done by 
Kavya et al showed a mortality of 18%. These results were comparable. Out of 
the 29 patients who required ventilator support, 9 died and 20 survived. None of 
the non-ventilator patients died. Ventilator support was directly related with high 
survival rates. 
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  Out of the 9 deaths, 6 were due to intermediate syndrome and 3 were due to 
ventilator assisted pneumonia. The cause of death in OPC poisoning, as studied 
by Kiran et al 79, showed intermediate syndrome to be the most common cause 
(46%), followed by ventilator associated pneumonia (26%), ARDS (8%) and 
MODS (8%). Aziza et al 80 has reported a mortality of 8% while Safdar et al 81 
has reported a mortality of 21.4%, in patients who received ventilator assistance.  
 
In our study, mean delay in admission for mechanically ventilated patients was 
3.59 hours, while that of non-ventilated patients was 3.95 hours. This association 
was statistically non-significant, but Rajeev et al has shown that he need for 
mechanical ventilation was directly proportional to the mean delay in 
presentation. Sunderam et al49 reported higher mortality rate in patients who 
presented more than 4 hours after consumption of OPC poison. In the study by 
Gupta et al, all deaths were due to delayed presentation of more than 8 hours from 
consumption. 
 In our study, mortality was highest with Phorate (50%) followed by 
Prophenophos (28.6%) and Monocrotophos (21.4%). Rajeev et al reported higher 
death rates with Methyl parathion and Dimethoate. In a study by Eddleston et al, 
the toxicity and mortality rates of each compound shows a linear relationship with 
absorption of the compound from GIT, deposition in various tissues, 
pharmacokinetics and irreversible inhibition of acetyl cholinesterase. 100% of the 
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patients who consumed Phorate required ventilator support, while 92.9% of the 
patients who consumed Mnocrotophos required ventilator assistance. None of the 
patients who consumed Diazinon, Malathion or Quinolphos needed mechanical 
ventilation. 
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CONCLUSION 
 
 An increased POPS score in patients with OP poisoning is 
associated with increased risk of respiratory failure and increases 
the need of ventilator support. 
 
 Serum pseudocholinesterase is a useful marker for predicting 
clinical outcome in OP poisoning as marked reductions are 
associated with increased need for ventilator support. 
 
 
  Hypokalemia at the time of presentation has detrimental effect 
on clinical outcome as it increases requirement of ventilator 
support. 
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SUMMARY 
 
This study was conducted with a sample size of 100 patients presented with OP 
poisoning in our hospital during June 2015-June2016.Majority of the patients 
were below 20 years of age with a male preponderance. Most of them were 
agricultural labourers and 96% of patients consumed poison with a suicidal 
intention. The most common compound consumed was Monocrotophos.  
Increased severity of the poisoning according to POPS score was associated with 
more reduction in serum pseudocholinesterase, high dose of atropine for 
treatment, long duration of hospital stay, increased requirement of ventilator 
support and increased mortality. Individual parameters of POPS score also 
correlated well with the clinical outcome. 
Reduction in the serum pseudocholinesterase showed a linear relationship with 
severity of poisoning. Marked reductions of the enzyme was associated with 
increased risk of respiratory failure, higher dose of atropine and increased 
mortality.Low serum potassium levels at the time of presentation adversely 
affected the clinical outcome. 
Our study shows that Peradeniya OP poisoning scale, serum 
pseudocholinesterase and serum potassium are useful markers to predict clinical 
outcome in patients presenting with OP poisoning. 
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PROFORMA 
 
Name: 
Age/Sex: 
Address: 
 
 
Occupation: 
IP No: 
D.O.A: 
D.O.D/D.O.E: 
 
 
 
 
Compound identified: 
 
Intention of poisoning:  Suicidal/Homicidal/Accidental 
 
COMPLAINTS OF THE PATIENT 
1.Excessive secretions               :YES/NO 
2.Breathlessness                         :YES/NO 
3.Vomiting                                    :YES/NO 
4.Diarrhoea                                   :YES/NO 
5.Loss of consciousness              :YES/NO 
6.Seizures                                      :YES/NO 
7.Neck muscle weakness            :YES/NO 
 
Whether stomach wash was given:YES/NO 
Date & Time of Consumption Date &Time of Admission Delay in admission 
      (Hours) 
   
PAST HISTORY 
H/O DM/HTN/SEIZURE DISORDER/BRONCHIAL 
ASTHMA/COPD/PTB/CAD/OTHERS 
 
PERSONAL HISTORY 
DIET                    : Vegetarian/Non vegetarian 
SMOKING           :YES/NO 
ALCOHOLISM    :YES/NO 
 
 
CLINICAL FEATURES: 
 
VITAL SIGNS 
BP PULSE RATE RESPIRATORY 
RATE 
OXYGEN SATURATION 
AT ROOM AIR 
    
 
SYSTEMIC EXAMINATION 
 
1.CARDIOVASCULAR SYSTEM: 
 
 
 
2.RESPIRATORY SYSTEM       : 
 
 
 
3.PER ABDOMEN                   : 
 
 
 
4.NERVOUS SYSTEM             : 
PERADENIYA OP POISONING SCALE 
Sl.No    PARAMETER SCORE 
1 MIOSIS 
Pupil>2mm 
Pupil<2mm 
Pupils pin point 
 
            0 
            1 
            2 
2 FASCICULATIONS 
None 
Present but not generalized or 
continuous 
 
Generalized and continuous 
 
            0 
 
            1 
 
            2 
 
3 RESPIRATORY RATE 
Respiratory rate<20/min 
Respiratory rate>20/min 
Respiratory rate>20/min with  central 
cyanosis 
 
           0 
           1 
 
           2 
4 PULSE RATE 
Pulse rate>60/min 
Pulse rate 41-60/min 
Pulse rate<40/min 
 
            0 
            1 
            2 
5 LEVEL OF CONSCIOUSNESS 
Conscious and rationale 
Impaired,responds to verbal commands 
Impaired,no response to verbal 
commands 
 
            0 
            1 
 
            2 
6 SEIZURES 
Absent 
Present 
 
            0 
            1 
                                TOTAL  
 
INVESTIGATIONS 
 
PARAMETERS LAB VALUE 
Total count  
Blood urea  
Serum creatinine  
Blood sugar  
Serum potassium  
Serum sodium  
Serum pseudocholinesterase  
 
TREATMENT GIVEN 
Duration of treatment               : 
Total dose of atropine given     : 
Whether patient required ventilator support :YES/NO 
 
OUTCOME 
 
 
If died,cause of death: 
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1 SHANMUGAVEL 55 M Agriculture Labourer 5 PHORATE S 9 4.1 528 severe 6 552 Y DIED IMS 
2 PERUMAL 70 M UNEMPLOYED 2 DIAZINON S 1 3.9 4800 mild 5 360 N IMPROVED  
3 SUGANYA 18 F STUDENT 2 CHLORPYRIFOS S 10 4.2 310 severe 5 504 Y DIED IMS 
4 KUMARESAN 23 M Agriculture Labourer 3 MONOCROTOPHOS S 8 3.8 930 moderate 11 552 Y DIED VAP 
5 PRAKASH 25 M 
WORK SHOP 
EMPLOYEE 
4 PROFENOFOS S 3 3.8 2860 mild 7 444 Y IMPROVED  
6 GOVINDAN 52 M Agriculture Labourer 3 MONOCROTOPHOS S 8 3.8 890 moderate 12 528 Y IMPROVED  
7 RASI 50 M Agriculture Labourer 3 PHORATE S 6 3.6 640 severe 5 432 Y DIED IMS 
8 SIVA 18 M STUDENT 4 DICHLORFOS S 2 3.9 2200 moderate 7 408 N IMPROVED  
9 VIVIN 13 M STUDENT 3 QUINOLFOS S 1 3.9 6800 mild 5 96 N IMPROVED  
10 SARAVANAN 32 M SHOP KEEPER 2 DICHLORFOS S 7 4 2100 moderate 8 396 N IMPROVED  
11 MAHESHWARAN 35 M WEAVER 2 CHLORPYRIFOS S 7 3.3 616 severe 10 480 Y IMPROVED  
12 PADMA 45 F Agriculture Labourer 4 PROFENOFOS S 3 3.9 3200 mild 6 156 N IMPROVED  
13 GOKULAKANNAN 19 M STUDENT 3 MONOCROTOPHOS S 10 3.9 310 severe 8 444 Y DIED VAP 
14 MALLIGA 18 F SALES GIRL 3 DIFENOFOS S 3 4 3820 mild 5 132 N IMPROVED  
15 TAMIL SELVAN 20 M Agriculture Labourer 5 CHLORPYRIFOS S 1 3.9 5600 mild 5 108 N IMPROVED  
16 GOKUL 17 M STUDENT 3 MALATHION S 1 3.9 5800 mild 5 48 N IMPROVED  
17 JAYAPRIYA 17 F STUDENT 2 PROFENOFOS S 8 3.9 436 severe 5 444 Y DIED IMS 
18 DURAISAMY 55 M Agriculture Labourer 4 MONOCROTOPHOS S 8 4 426 severe 9 408 Y IMPROVED  
19 RAJKUMAR 23 M SALES EXECUTIVE 2 MALATHION S 1 3.9 6800 mild 4 96 N IMPROVED  
20 GANESAN 45 M TEACHER 2 DICHLORFOS S 3 4.3 3800 mild 5 192 N IMPROVED  
21 MADHIVANAN 15 M STUDENT 3 QUINOLFOS A 2 3.9 3720 mild 6 192 N IMPROVED  
22 RATHNAVEL 50 M Agriculture Labourer 5 DICHLORFOS S 5 3.9 1020 moderate 8 408 Y IMPROVED  
23 MARIMUTHU 57 M Agriculture Labourer 4 MONOCROTOPHOS S 5 4.1 1800 moderate 10 504 N IMPROVED  
24 NERIYAPPAN 60 M Agriculture Labourer 2 PROFENOFOS S 8 4.1 910 moderate 7 408 Y DIED IMS 
25 MAKHILA 18 F STUDENT 3.5 CHLORPYRIFOS S 8 3.5 1700 moderate 7 480 Y IMPROVED  
26 SAHADEVAN 74 M Agriculture Labourer 5 MONOCROTOPHOS S 6 3.4 224 severe 8 492 Y DIED VAP 
27 BALASUBRAMANI 35 M TEACHER 4 CHLORPYRIFOS S 4 3.3 980 moderate 7 502 Y IMPROVED  
28 PRIYA 19 F STUDENT 6 MALATHION S 1 4.3 7600 mild 5 144 N IMPROVED  
29 PADMA 45 F HOUSE WIFE 4 MONOCROTOPHOS S 5 4 1010 moderate 17 624 Y IMPROVED  
30 ANANDHARAJ 60 M Agriculture Labourer 4 PROFENOFOS S 1 4.5 6100 mild 4 144 N IMPROVED  
31 NANDHAKUMAR 24 M Agriculture Labourer 6 DICHLORFOS S 1 3.8 4300 mild 5 60 N IMPROVED  
32 MARUTHAI 50 M WEAVER 4 MONOCROTOPHOS S 8 3.2 800 severe 12 408 Y IMPROVED  
33 PRASHANT 13 M STUDENT 6 MALATHION A 1 3.9 5080 mild 5 96 N IMPROVED  
34 USHA 14 F STUDENT 4 DIFENOFOS S 8 3.1 360 severe 13 456 Y IMPROVED  
35 RAJA 16 M STUDENT 3 MONOCROTOPHOS S 8 3.8 400 severe 14 456 Y IMPROVED  
36 SURESH KUMAR 50 M Agriculture Labourer 3 MONOCROTOPHOS S 8 3.6 423 severe 12 492 Y IMPROVED  
37 SREENIVASAN 33 M Agriculture Labourer 3.5 CHLORPYRIFOS S 6 3.8 1200 moderate 8 468 Y IMPROVED  
38 THANGAYYAN 32 M Agriculture Labourer 6 PROFENOFOS S 2 3.9 5240 mild 4 144 N IMPROVED  
39 MUNUSAMY 55 M Agriculture Labourer 4 MONOCROTOPHOS S 5 4.4 2800 mild 8 480 Y IMPROVED  
40 VINOTH KUMAR 26 M Agriculture Labourer 2 MALATHION S 0 4.3 7800 mild 3 96 N IMPROVED  
41 SELVI 20 F HOUSE WIFE 5 MONOCROTOPHOS S 9 3.1 240 severe 5 528 Y IMPROVED  
42 PAPPATHI 30 F Agriculture Labourer 4 PHORATE S 8 3.6 980 moderate 4 480 Y DIED IMS 
43 MANI 35 F Agriculture Labourer 5 PROFENOFOS S 3 4.3 3800 mild 6 266 N IMPROVED  
44 VENKATESH 35 M 
CONSTRUCTION 
WORKER 
5 DIAZINON S 5 3.6 2810 mild 6 336 N IMPROVED  
45 AYYA SAMY 40 M Agriculture Labourer 6 CHLORPYRIFOS S 4 4.1 4700 mild 6 228 N IMPROVED  
46 MEERA 18 F STUDENT 2 PHORATE S 6 3.8 516 severe 11 528 Y IMPROVED  
47 BAKKIYAM 61 F HOUSE WIFE 4 MONOCROTOPHOS S 8 3.6 910 moderate 10 540 Y IMPROVED  
48 DHANAM 48 F Agriculture Labourer 5 PHORATE S 9 3.7 412 severe 12 516 Y IMPROVED  
49 KUPPAN 65 M Agriculture Labourer 5 MONOCROTOPHOS S 8 4 310 severe 8 492 Y IMPROVED  
50 PALANIYAPPAN 46 M HOTEL WORKER 4 PHORATE S 8 3.9 930 moderate 8 444 Y IMPROVED  
 
